Literature DB >> 2466597

Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings.

A Schiavinato1, E Lini, D Guidolin, G Pezzoli, P Botti, M Martelli, R Cortivo, A De Galateo, G Abatangelo.   

Abstract

The effect of the intraarticular sodium hyaluronate (HA) injection on the osteoarthritic knee joint has been evaluated in dogs using an experimental model of osteoarthritis induced by sectioning the anterior cruciate ligament. Seven weeks after surgery, the damage, graded according to Mankin's scale, was significantly reduced in knee joints treated with HA from the second week postsurgery compared to untreated joints. When intraarticular HA therapy was initiated after the seventh week, osteoarthritis progression was still reduced compared to controls. Both morphology and morphometry showed a beneficial effect of HA on the cartilage response to the damage, as well as a clearcut inhibitory effect on the development of the fibroblastlike cell layer on the articular cartilage in untreated joints. The beneficial effects on the cartilage integrity and response to osteoarthritic damage might be related to a primary effect of HA on the cartilage surface. However, these effects do not exclude the possibility that, in addition, HA might act on the synovial membrane by limiting the synovial reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466597

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

Review 1.  Hyaluronate in rheumatology and orthopaedics: is there a role?

Authors:  R K Strachan; P Smith; D L Gardner
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 2.  State-of-the-art disease-modifying osteoarthritis drugs.

Authors:  Roland W Moskowitz; Michele Hooper
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

3.  Jellyfish mucin may have potential disease-modifying effects on osteoarthritis.

Authors:  Naoshi Ohta; Masato Sato; Kiminori Ushida; Mami Kokubo; Takayuki Baba; Kayoko Taniguchi; Makoto Urai; Koji Kihira; Joji Mochida
Journal:  BMC Biotechnol       Date:  2009-12-08       Impact factor: 2.563

4.  Effects of supplemental intra-articular lubricin and hyaluronic acid on the progression of posttraumatic arthritis in the anterior cruciate ligament-deficient rat knee.

Authors:  Erin Teeple; Khaled A Elsaid; Gregory D Jay; Ling Zhang; Gary J Badger; Matthew Akelman; Thomas F Bliss; Braden C Fleming
Journal:  Am J Sports Med       Date:  2010-09-20       Impact factor: 6.202

Review 5.  A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.

Authors:  M E Adams; A J Lussier; J G Peyron
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

Review 6.  Current pharmacological treatment of osteoarthritis.

Authors:  F A Wollheim
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 7.  Osteoarthritis. A continuing challenge.

Authors:  K E Sack
Journal:  West J Med       Date:  1995-12

Review 8.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

9.  Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes.

Authors:  Valentina Grishko; Min Xu; Renee Ho; Aaron Mates; Scott Watson; Jong T Kim; Glenn L Wilson; Albert W Pearsall
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

10.  Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis.

Authors:  T Pham; A Le Henanff; Ph Ravaud; P Dieppe; L Paolozzi; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-08-26       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.